Clinical Trial Update: Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a pazopanib and weekly topotecan combination for recurrent ovarian cancer (TOPAZ), spanning Phase 1 and Phase 2 stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Topotecan (topotecan)
• Votrient (Pazopanib)

Snippet

Sponsor: JSehouli | Conditions: Ovarian Cancer | Phase 1, Phase 2 | Status: UNKNOWN